Type 2 Gaucher disease: An expanding phenotype

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 209-219

  Tayebi, Nahid ^a   Stone, Deborah L ^a   Sidransky, Ellen ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Congenital ichthyosis; Genotype; Glucocerebrosidase deficiency; Hydrops fetalis; Lethal

Indexed keywords

ALGLUCERASE; GLUCOSYLCERAMIDASE; IMIGLUCERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE DISEASE; CARDIOVASCULAR DISEASE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; CYTOPENIA; ENZYME DEFICIENCY; ENZYME REPLACEMENT; FETUS HYDROPS; GAUCHER DISEASE; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; HYDROCEPHALUS; INFANT; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SHORT SURVEY; SKIN BIOPSY;

ANIMALIA; HYDROPS;

EID: 0032708436     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2918     Document Type: Article

References (80)

1. Beutler E, Grabowski G A. Gaucher disease. Scriver C R, Beaudet A L, Sly W S. The Metabolic and Molecular Bases of Inherited Disease. 1995;2641-2670 McGraw-Hill, New York.
2. Frederickson D S, Sloan H R. Glucosylceramide lipidoses: Gaucher's disease. Stanbury J B, Wyngaarden J B, Frederickson D S. The Metabolic Basis of Inherited Disease. 1972;730-759 McGraw-Hill, New York.
3. Sidransky E. New perspectives in type 2 Gaucher disease. Adv in Pediatr. 44:1997;73-107.
4. Cogan D G, Chu F C, Reingold D, Barranger J. Ocular motor signs in some metabolic diseases. Arch Ophthalmol. 99:1981;1802-1808.
5. Liu K, Commens C, Chong R, Jaworski R. Collodion babies with Gauchers disease. Arch Dis Child. 63:1988;854-856.
6. Sidransky E, Sherer D M, Ginns E I. Gaucher disease in the neonate: A distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res. 32:1992;494-498.
7. Abrahamov A, Elstein D, Gross-Tsur V, Farber B, Glaser Y, Hadas-Halpern I, Ronen S, Tafakjdi M, Horowitz M, Zimran A. Gaucher's disease variant characterized by progressive calcification of heart valves and unique genotype. Lancet. 346:1995;1000-1003.
8. Uyama E, Takahashi K, Owada M, Okamura R, Naito M, Tsuji S, Kawasaki S, Araki S. Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: A new syndrome associated with glucocerebrosidase deficiency and a mosaic population of storage cells. Acta Neurol Scand. 86:1992;407-420.
9. Elstein D, Klutstein M W, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet. 351:1998;1544-1546.
10. Neudorder O, Giladi N, Elstein D, Abrahamov A, Turezkite T, Aghai E, Reches A, Bembi B, Zimran A. Occurrence of Parkinson's syndrome in type 1 Gaucher disease. Q J Med. 89:1996;691-694.
11. Oberling C, Woringer P. La Maladie de Gaucher chez le nourrissor. Rev Fr Pediatr. 3:1927;475-532.
12. Brady R O, Kanfer J N, Shapiro D. Metabolism of glucocerebrosides. II. Evidence of enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun. 18:1965;221-225.
13. Beutler E, Kuhl W. Detection of the defect of Gaucher's disease and its carrier state in peripheral-blood leukocytes. Lancet. 1:1970;612-613.
14. Evans M I, Moore C, Kolodny E H, Casassa M, Schulman J D, Landsberger E J, Karson E M, Dorfman A D, Larsen J W Jr, Barranger J A. Lysosomal enzymes in chorionic villi, cultured amniocytes, and cultured skin fibroblasts. Clin Chim Acta. 157:1986;109-113.
15. Sidransky E, Ginns E I. Phenotypic and genotypic heterogeneity in Gaucher disease: Implications for genetic counseling. J Genet Couns. 3:1994;13-22.
16. Grabowski G A. Gaucher disease. Enzymology, genetics and treatment. Adv Hum Genet. 21:1993;377-441.
17. Tybulewicz V LJ, Tremblay M L, LaMarca M E, Willemsen R, Stubblefield B K, Winfield S, Zablocka B, Sidransky E, Martin B M, Huang S P, Mintzer K A, Westphal H, Mulligan R C, Ginns E I. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature. 357:1992;407-410.
18. Lipson A H, Rogers M, Berry A. Collodion babies with Gaucher's disease: A further case. Arch Dis Child. 66:1991;667.
19. Rowlands S, Murray H. Prenatal ultrasound findings in a fetus diagnosed with Gaucher's disease (type 2) at birth. Prenat Diag. 17:1997;765-769.
20. Sherer D M, Metlay L, Sinkin R A, Mongeon C, Lee R E, Wood S Jr. Congenital ichthyosis with restrictive dermopathy and Gaucher's disease: A new syndrome with associated prenatal diagnostic and pathology findings. Obstet Gynecol. 81:1993;843-844.
21. Ince Z, Coban A, Peker O, Ince U, Can G. Gaucher disease associated with congenital ichthyosis in the neonate. Eur J Pediatr. 154:1995;418.
22. Stone D L, vanDiggelen O P, deKlerk J BC, Gaillard J LJ, Niermeijer M F, Willemsen R, Tayebi N, Sidransky E. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease. Eur J Hum Genet. 7:1999;505-509.
23. Sidransky E, Tayebi N, Stubblefield B K, Eliason W, Klineburgess A, Pizzolato G-P, Cox J N, Porta J, Bottani A, DeLozier-Blanchet C D. The clinical, molecular, and pathological characterization of a family with two cases of lethal perinatal type 2 Gaucher disease. J Med Genet. 33:1996;132-136.
24. Grace M E, Ashton-Prolla P, Pastores G M, Soni A, Desnick R J. Non-pseudogene-derived complex acid β-glucosidase mutations causing mild type 1 and severe type 2 Gaucher disease. J Clin Invest. 103:1999;817-823.
25. Fujimoto A, Tayebi N, Sidransky E. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease. Am J Med Genet. 59:1995;356-358.
26. Holleran W M, Ginns E I, Menon G K, Grundmann J U, Fartasch M, McKinney C, Elias P M, Sidransky E. Consequences of β-glucocerebrosidase deficiency in epidermis: Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest. 93:1994;1756-1764.
27. Yardley H J, Summerly R. Lipid metabolism in normal and diseased epidermis. Pharmacol Ther. 13:1981;347-383.
28. Holleran W M, Takagi Y, Menon G K, Legler G, Feingold K R, Elias P M. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest. 91:1993;1656-1664.
29. Elias P M, Menon G K. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 24:1991;1-26.
30. Sidransky E, Fartasch M, Lee R E, Metlay L A, Abella S, Zimran A, Gao W, Elias P M, Ginns E I, Holleran W M. Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res. 39:1996;134-141.
31. Tayebi N, Reissner K, Lau E K, Stubblefield B K, Sidransky E. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher disease. Pediatr Res. 43:1998;571-578.
32. Reissner K, Tayebi N, Stubblefield B K, Blitzer M, Madellena A, Carson E, Sidransky E. Heteroallelism for a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus presenting with hydrops fetalis. Mol Genet Metab. 63:1998;281-288.
33. Erikson A, Johansson K, Mansson J E. Enzyme replacement therapy of infantile Gaucher disease. Neuropediatrics. 24:1993;237-238.
34. Bove K E, Daugherty C, Grabowski G A. Pathological finding in Gaucher disease type 2 patient following enzyme therapy. Hum Pathol. 26:1995;1040-1045.
35. Bembi B, Ciana G, Zanatta M, Bottega M, Pelos G, Gornati R, Berra B. Cerebrospinal-fluid infusion of alglucerase in the treatment of acute neuronopathic Gauchers disease. Pediatr Res. 38:1995;A425.
36. Strasberg P M, Skomorowski M A, Warren I B, Hilson W L, Callahan J W, Clarke J TR. Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: Is this analogous to the Gaucher knock-out mouse model. Biochem Med Metab Biol. 53:1994;16-21.
37. Tayebi N, Cushner S, Kleijer W, Lau E, Damschroder-Williams P J, Stubblefield B K, Hollander J D, Sidransky E. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene. Am J Med Genet. 73:1997;41-47.
38. Eto Y, Ida H. Clinical and molecular characteristics of Japanese Gaucher disease. Neurochem Res. 24:1999;207-211.
39. Vervoort R, Islam M R, Sly W S, Zabot M T, Kleijer W J, Chabas A, Fensom A, Young E P, Liebaers I, Lissens W. Molecular analysis of patients with β-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet. 58:1996;457-471.
40. Applegarth D A, Toone J R, Wilson R D, Yong S L, Baldwin V J. Morquio disease presenting as hydrops fetalis and enzyme analysis of chorionic villus tissue in a subsequent pregnancy. Pediatr Pathol. 7:1987;593-599.
41. Pueschel S M, O'Shea P A, Alroy J, Ambler M W, Dangond F, Daniel P F, Kolodny E. Infantile sialic acid storage disease associated with renal disease. Pediatr Neurol. 4:1988;207-212.
42. Zammarchi E, Donati M A, Morrone A, Donzelli G P, Zhou X Y, d'Azzo A. Early-infantile galactosialidosis: Clinical, biochemical, and molecular observations in a new patient. Am J Med Genet. 64:1996;453-458.
43. MI-gangliosidosis presenting as nonimmune hydrops fetalis: A case report. J Perinat Med. 24:1996;445-449.
44. Aylsworth A S, Thomas G H, Hood J L, Malouf N, Libert J. A severe infantile sialidosis: Clinical, biochemical and microscopic features. J Pediatr. 96:1980;662-668.
45. Maconochie I K, Chong S, Mieli-Vergani G, Lake B D, Mowat A P. Fetal ascites: An unusual presentation of Niemann-Pick disease type C. Arch Dis Child. 64:1989;1391-1393.
46. Kattner E, Schäfer A, Harzer K. Hydrops fetalis: Manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr. 156:1997;292-295.
47. 450 in the amniotic fluid. Obstet Gynecol. 71:1988;1005-1008.
48. Willemsen R, Tybulewicz V, Sidransky E, Eliason W K, Martin B M, LaMarca M E, Reuser A JJ, Tremblay M, Westphal H, Mulligan R, Ginns E I. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol. 24:1995;170-192.
49. Nilsson O, Svennerholm L. Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver. J Lipid Res. 23:1982;327-333.
50. McKinney C E, Sidransky E, LaMarca M E, Riviere I, Holleran W M, Martin B M, Willemsen R, Mulligan R C, Ginns E I. Gaucher disease: A tale of two species. Ment Retard Dev Disabil Res Rev. 1:1995;79-86.
51. Orvisky E, Martin B M, Tayebi N, Karson E, Samimi R, Sciarretta K, Ginns E I, Sidransky E. Glucosylsphingosine accumulation in patients with type 2 Gaucher occurs early in gestation. Am J Hum Genet. 63:1998;A271.
52. Tanaka K, Nagara H, Kobayashi T, Goto I. The Twitcher mouse: Accumulation of galactosylsphingosine and pathology of the central nervous system. Brain Res. 482:1989;347-350.
53. Suzuki K, Suzuki Y. Galactoceramide lipidosis: Globoid cell leukodystrophy. Stanbury J B, Wyngarden J B, Fredrickson D S. The Metabolic Basis of Inherited Disease. 1983;857-880 McGraw Hill, New York.
54. Beutler E, Gelbart T. Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis. 24:1998;2-8.
55. Grabowski G A, Horowitz M. Gaucher's disease: Molecular, genetic and enzymological aspects. Zimran A. Gaucher's Disease: Baillière's Clinical Haematology. 1997;635-656 Baillière Tindall, London.
56. Tsuji S, Choudary P V, Martin B M, Stubblefield B K, Mayor J A, Barranger J A, Ginns E I. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med. 316:1987;570-575.
57. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: Structure and evolution. Genomics. 4:1989;87-96.
58. Long G L, Winfield S, Adolph K W, Ginns E I, Bornstein P. Structure and organization of the human metaxin gene (MTX) and pseudogene. Genomics. 33:1996;177-184.
59. Latham T, Grabowski G A, Theophilus B DM, Smith F I. Complex alleles of the acid β-glucocerebrosidase gene in Gaucher disease. Am J Hum Genet. 47:1990;49-86.
60. Horowitz M, Zimran A. Mutations causing Gaucher disease. Hum Mutat. 3:1994;1-11.
61. Tayebi N, Stern H, Dymarskaia I, Herman J, Sidransky E. 55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles. Am J Med Genet. 66:1996;316-319.
62. Tayebi N, Cushner S R, Sidransky E. Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: Implications for Gaucher disease. Am J Hum Genet. 59:1996;740-741.
63. Stone, D, Tayebi, N, Stubblefield, B, Madike, V, Sidransky, E, Glucocerebroside mutations encountered in patients with type 2 Gaucher disease. Submitted for publication.
64. Ida H, Rennert O M, Kawame H, Ito T, Maekawa K, Eto Y. Mutation screening of 17 Japanese patients with neuropathic Gaucher's disease. Hum Genet. 98:1996;167-171.
65. Grace M E, Desnick R J, Pastores G M. Identification and expression of acid β-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher's disease in non-Jewish patients. J Clin Invest. 99:1997;2530-2537.
66. Latham T E, Theophilus B DM, Grabowski B A, Smith P I. Heterogeneity of mutations in the acid-glucosidase gene of Gaucher's disease patients. DNA Cell Biol. 10:1991;15-21.
67. Eyal N, Wilder S, Horowitz M. Prevalent and rare mutations among Gaucher patients. Gene. 96:1990;277-283.
68. Beutler E, Gelbart T. Two new Gaucher's disease mutations. Hum Genet. 93:1994;209-210.
69. Zimran A, Elstein D, Abrahamov A, Kuhl W, Brown K H, Beutler E. Prenatal molecular diagnosis of Gaucher. Prenat Diagn. 15:1995;1185-1188.
70. 6490→ A substitution at the last nucleotide of exon 10 of the glucocerebrosidase gene in two unrelated Italian Gaucher patients. Clin Genet. 48:1995;123-127.
71. Uchiyama A, Tomatsu S, Kondo N, Suzuki Y, Shimozawa N, Fukuda S, Sukegawa K, Taki N, Inamori H, Orii T. New Gaucher's disease mutations in exon 10: A novel L444R mutation produces a new NciI site the same as L444P. Hum Mol Genet. 3:1994;1183-1184.
72. Choy F YM, Wei C. Identification of a new mutation (P178S) in an African-American patient with type 2 Gaucher's disease. Hum Mutat. 5:1995;345-347.
73. Hatton C E, Cooper A, Whitehouse C, Writh J E. Mutation analysis in 46 British and Irish patients with Gaucher's disease. Arch Dis Child. 77:1997;17-22.
74. Sinclair G, Choy F YM, Humphries L. A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease. Blood Cells Molecules Dis. 24:1998;420-427.
75. Deming A, Beutler E. Six new Gaucher disease mutations. Acta Haematol. 99:1998;80-82.
76. Winfield S L, Tayebi N, Martin B M, Ginns E I, Sidransky E. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: Implications for Gaucher's disease. Genome Res. 7:1997;1020-1026.
77. Hanes J J, von der Kammer H, Klaudiny J J, Scheit K H. Characterization by cDNA cloning of two new human protein kinases: Evidence by sequence comparison for a new family of mammalian protein kinases. J Mol Biol. 244:1994;665-672.
78. Brand S H, Castle J D. SCAMP 37, a new marker within the general cell surface recycling system. EMBO J. 12:1993;3753-3761.
79. Sidransky E, Ginns E I. Gaucher disease plus. J Med Genet. 34:1997;876-879.
80. Platt F M, Neises G R, Karlsson G B, Dwek R A, Butters T P. N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. J Biol Chem. 43:1994;27108-27114.